Similar articles

• Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

  Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Ursin G, et al. J Natl Cancer Inst. 1999 Jun 16;91(12):1067-72. doi: 10.1093/jnci/91.12.1067. J Natl Cancer Inst. 1999. PMID: 10379970
• A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

  Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Ursin G, et al. Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):601-5. doi: 10.1289/ehp.97105s3601. Environ Health Perspect. 1997. PMID: 9168002 Free PMC article.
• Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

  Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Muti P, et al. Epidemiology. 2000 Nov;11(6):635-40. doi: 10.1097/00001648-200011000-00004. Epidemiology. 2000. PMID: 11055622
• [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].

  Mueck AO, Seeger H, Lippert TH. Mueck AO, et al. Zentralbl Gynakol. 2003 Nov;125(11):458-66. doi: 10.1055/s-2003-44575. Zentralbl Gynakol. 2003. PMID: 14634875 Review. German.
• Risk factors for breast cancer development.

  Henderson IC. Henderson IC. Cancer. 1993 Mar 15;71(6 Suppl):2127-40. doi: 10.1002/1097-0142(19930315)71:6+<2127::aid-cncr2820711602>3.0.co;2-2. Cancer. 1993. PMID: 8443762 Review. No abstract available.